Loss of chromosome 18q11.2-q12.1 is predictive for survival in patients with metastatic colorectal cancer treated with bevacizumab - Dijk, Erik van; Biesma, Hedde D.; Cordes, Martijn; Smeets, Dominiek; Neerincx, Maarten; Das, Sudipto; Eijk, Paul P.; Murphy, Verena; Barat, Anna; Bacon, Orna; Prehn, Jochen H. M.; Betge, Johannes; et al. (Journal of clinical oncology, 2018)
Gesehen am 13.03.2020